What drives the recent surge in glutamic acid production efficiency improvements?

What drives the recent surge in glutamic acid production efficiency improvements?
Recent patent disclosures reveal a clear trend: producers are racing to squeeze more output from Corynebacterium glutamicum strains. Fufeng's patents target RND family transporters and biotin protein ligase mutations, while Daesang's work on polyphosphate kinase 2B inactivation shows yield gains of 7.9% under normal conditions and 16.5% under phosphate-limited media. These incremental gains matter because feedstock costs—corn and starch—dominate production economics. Even a 10% yield improvement can shift margin structures significantly in a commodity market where global capacity is concentrated among a few Chinese and Japanese players. The focus on metabolic pathway tweaks suggests fermentation technology is maturing, with innovation shifting from process scale-up to genetic optimization.